FTC Sues Hims & Hers Over Deceptive Billing and Privacy Practices

What happened

The US Federal Trade Commission has filed a lawsuit against Hims & Hers, the direct-to-consumer telehealth and wellness platform, alleging that the company engaged in deceptive billing practices and violated consumer privacy. At the centre of the complaint is the allegation that Hims & Hers failed to make sufficiently clear to consumers that a charge for a prescription would be triggered almost immediately after they completed an intake form — before many users understood they had committed to a purchase.

The FTC's action signals continued regulatory scrutiny of subscription-adjacent billing models in digital health, where the line between "browsing" and "buying" is frequently blurred by onboarding flows designed to reduce friction and accelerate conversion.

Why it matters

For customer experience and service-design practitioners, this case is a textbook illustration of what happens when conversion optimisation is pursued at the expense of informed consent. Hims & Hers built its brand on removing the awkwardness and delay from accessing healthcare — a genuinely valuable CX proposition. But the FTC's complaint suggests that the same frictionless design that made the service appealing may have obscured a critical decision point: the moment a consumer incurs a financial obligation. In behavioral economics terms, this is a dark-pattern concern — where interface choices exploit present bias and low-effort defaults to commit users to transactions they did not consciously authorise.

The privacy dimension compounds the reputational risk. Telehealth platforms handle some of the most sensitive personal data in any consumer category. When billing opacity and privacy concerns appear together in a single regulatory complaint, the trust damage extends well beyond the legal exposure — it strikes at the core emotional contract between a health brand and its users.

The Renascence take

The Hims & Hers case is not really about a rogue checkout flow. It reflects a structural tension that runs through every subscription and usage-based business: the incentive to minimise the psychological "cost" of signing up can quietly migrate into minimising the user's awareness that they are signing up at all. That is a design choice with consequences.

What most operators miss is that transparency at the point of commitment is not a conversion killer — it is a retention asset. Consumers who understand exactly what they are agreeing to are less likely to dispute charges, churn in anger or file complaints. The behavioral principle here is procedural fairness: people tolerate costs they chose, and resent costs that feel imposed. A customer-obsessed telehealth operator should treat the billing disclosure moment as a brand touchpoint, not a legal checkbox — making the value of the prescription explicit at the very instant the charge is explained, so the user's mental accounting frames cost and benefit together rather than in sequence.